Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA

被引:0
作者
Steven B. Deitelzweig
Belinda Lovelace
Mary Christoph
Melissa Lingohr-Smith
Jay Lin
Gregory J. Fermann
机构
[1] University of Queensland and Ochsner Clinical School,Department of Hospital Medicine
[2] Portola Pharmaceuticals,Department of Emergency Medicine
[3] Novosys Health,undefined
[4] University of Cincinnati,undefined
来源
Advances in Therapy | 2020年 / 37卷
关键词
Atrial fibrillation; Direct-acting oral anticoagulants; Factor Xa inhibitors; Healthcare costs; Healthcare resource utilization; Major bleed;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3942 / 3953
页数:11
相关论文
共 62 条
  • [41] Colman CI(undefined)undefined undefined undefined undefined-undefined
  • [42] Ashton V(undefined)undefined undefined undefined undefined-undefined
  • [43] Lip GY(undefined)undefined undefined undefined undefined-undefined
  • [44] Keshishian A(undefined)undefined undefined undefined undefined-undefined
  • [45] Kamble S(undefined)undefined undefined undefined undefined-undefined
  • [46] Lin J(undefined)undefined undefined undefined undefined-undefined
  • [47] Trocio J(undefined)undefined undefined undefined undefined-undefined
  • [48] Gupta K(undefined)undefined undefined undefined undefined-undefined
  • [49] Ntaios G(undefined)undefined undefined undefined undefined-undefined
  • [50] Papavasileiou V(undefined)undefined undefined undefined undefined-undefined